Results 171 to 180 of about 82,056 (314)
Prognostic Outcomes by Ishak Fibrosis Score Grouping in Biliary Atresia After Kasai Surgery. [PDF]
Huang L +12 more
europepmc +1 more source
Ascitic fluid concentrations of fibronectin and cholesterol [PDF]
Gerbes, Alexander L. +3 more
core
Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
Peroxisome proliferator‐activated receptor (PPAR) agonists have emerged as important second‐line treatments in primary biliary cholangitis, with profiles influenced by different selectivity for α‐, δ‐ and γ‐isoforms. PPAR‐α and PPAR‐δ agonism improve cholestasis, with inflammation reduced via all isoforms. PPAR‐δ agonism also reduces pruritus.
Jörn M. Schattenberg +8 more
wiley +1 more source
Leucine Aminopeptidase to Spleen Length Ratio: A Novel Noninvasive Model for Predicting Esophageal Gastric Variceal Bleeding in Patients With Liver Cirrhosis. [PDF]
Zhu C, Jiang Y, Liu Y, Bian Z, Luo L.
europepmc +1 more source
Disordered Bile Acid Metabolism in Alcohol‐Related Hepatitis
Serum conjugated primary bile acids accumulate in alcohol‐related hepatitis due to downregulation of hepatocyte bile acid transporters. Hepatocyte growth factor is elevated in alcohol‐related hepatitis and downregulates BSEP expression. This detrimentally affects the hepatoprotective adaptive reduction in NTCP/increase in BSEP seen in cholestasis ...
Luke D. Tyson +22 more
wiley +1 more source
Cure rate estimation with insufficient follow-up: A median-based bootstrap correction approach. [PDF]
Ibi Y, Omori T.
europepmc +1 more source
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo +13 more
wiley +1 more source
Preoperative Metabolic Risk Factors and Outcomes in Living Donor Liver Transplant in HBV Recipients. [PDF]
Koçulu Demir S +4 more
europepmc +1 more source
Seladelpar improved itch, itch‐related sleep disturbance and measures of fatigue in patients with primary biliary cholangitis and pruritus in the Phase 3 RESPONSE trial. ABSTRACT Background Pruritus and fatigue impose a significant burden on patient quality of life in primary biliary cholangitis (PBC).
Cynthia Levy +10 more
wiley +1 more source

